about
Pathophysiological role of host microbiota in the development of obesityProbiotics in prevention and treatment of obesity: a critical viewInsulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patientsAntioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility.Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease preventionPrevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles.The role of liver biopsy to assess non-alcoholic fatty liver disease.Caffeine and cardiovascular diseases: critical review of current research.The Role of Liver Biopsy to Assess Alcoholic Liver Disease.Perspectives and challenges of antioxidant therapy for atrial fibrillation.Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats.Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress.[Liver stiffness in animals with glutamate-induced obesity (according to shear wave ultrasound elastography)].Effects of polyphenol compounds melanin on NAFLD/NASH prevention.Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.The Impact of Hyperglycemia on VEGF Secretion in Retinal Endothelial Cells.A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial.H2S causes contraction and relaxation of major arteries of the rabbit.[Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease].Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver DiseaseProbiotics and nutraceuticals as a new frontier in obesity prevention and managementThe effects of Z56822977 on biosynthesis of serotonin in the brain of rats in the conditions of MSG-induced obesityNeuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case reportImportance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer CellsBeneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study[Determination of age-related liver stiffness changes in rats according to the ultrasonic shear wave elastography]New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study
P50
Q26750893-B4619A72-2715-451B-9E21-F38B060BC8C8Q26768518-7B679555-2307-4A84-911B-349AF1210F9BQ34467208-6FA281B3-8F95-4228-9EC1-CB7C3BC6862FQ34469086-FF73C92D-FAD3-485B-9818-980D13B17A08Q35626631-CAC36B65-A4A4-4BDC-B9EA-71966E97F9ADQ35762331-A3F78318-2522-488C-822C-51D8817524BDQ35956826-2CA94B2E-8265-4B2F-B6E4-16C9A5CF2573Q36848119-DCC19C1D-20AA-4B67-A269-37F7825E57B7Q38290696-686288C4-29F0-47A9-9A8A-3E20458562D2Q38757122-774A108F-FDC2-4640-9C42-39213F130478Q38908362-174E01BA-0F99-4EF9-A3F6-D3D8DC475800Q39024113-CCE3A225-253F-42D3-BF6F-3E0311978653Q40241603-153A7145-9A26-4F10-80B3-E4278194C4C6Q40497908-CFB6A002-6A58-43CD-9BB8-2D9796A1FF72Q45343881-5EB3B631-B71E-4F48-BDB5-5F7FC38F59B6Q46429591-9B96C251-F84F-4D52-A109-D15D2F5B535FQ47195243-3FD0BCA4-60DD-4123-802A-AA1A6F3EAE6DQ47577524-25904455-2CC8-4C25-8AEA-89F8E3B0F99CQ48338551-313E6CD4-33F6-4AC2-A346-8C450ADEB429Q50097281-CBB258FF-AA5B-4853-ADA6-913AE05F0A23Q50165402-91518842-679F-4108-8810-2BAA9B942EB8Q51737958-BECCFB75-D4B1-4DB2-B936-9F226963EFFCQ52381477-1676CB9D-3DD8-491B-A698-EE1C0682120AQ53495514-804DE9E0-D071-469C-B058-83E8AECF53AEQ54290751-512DEA84-8334-47F6-8270-F97F8676A23CQ57476681-5E474DA5-AE1D-4D38-8D2F-86165F1A1646Q88716945-D361F867-F951-4FD8-820E-1F76A3438A3DQ90670721-2C457855-6686-451B-BDFF-CEDBAC5F4BD1Q91039715-7F441002-2A57-4C3D-A0B7-A60382E0FD55Q91313077-8922EC63-3D34-4382-B530-DA65C566260AQ91478584-1616CB22-685E-4ED4-B839-BEF862CE1E8DQ95409498-1007DB11-329E-43CD-A777-ED7B29466475Q96576438-41CC1B2B-3875-40CF-9A33-5287C0FCDD2B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nazarii Kobyliak
@ast
Nazarii Kobyliak
@en
Nazarii Kobyliak
@es
Nazarii Kobyliak
@nl
Nazarii Kobyliak
@sl
type
label
Nazarii Kobyliak
@ast
Nazarii Kobyliak
@en
Nazarii Kobyliak
@es
Nazarii Kobyliak
@nl
Nazarii Kobyliak
@sl
prefLabel
Nazarii Kobyliak
@ast
Nazarii Kobyliak
@en
Nazarii Kobyliak
@es
Nazarii Kobyliak
@nl
Nazarii Kobyliak
@sl
P1053
R-8703-2016
P106
P1153
55831452300
P31
P3829
P496
0000-0001-9814-689X